Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Until recently, most Americans had never heard of chikungunya, a mosquito-transmitted disease caused by the chikungunya virus (CHIKV). This has changed as a result of an explosive outbreak of chikungunya throughout the Caribbean that has affected more than 580 000 people since December 2013.1 Although cases of chikungunya have been reported this year in the United States (eg, North Carolina, Florida, Indiana, Nebraska, Tennessee), these have virtually all been in travelers returning from the Caribbean or from chikungunya-endemic areas of Africa or Asia.1 However, various data suggest that it is only a matter of time until CHIKV transmission is autochthonous in the continental United States and chikungunya becomes a public health problem.2-4 The likelihood of this scenario is heightened because of the presence of (1) CHIKV replication-competent mosquito vectors (ie, Aedes albopictus and Aedes aegypti); (2) a temperate climate, particularly in the southeastern United States, that is conducive to the establishment of endemic foci of chikungunya; (3) a highly susceptible population with no preexisting immunity to the virus; and (4) a large influx of viremic travelers returning from the Caribbean, coupled with the seasonal synchronicity of vector activity.
Stamm LV. ChikungunyaEmerging Threat to the United States. JAMA Dermatol. 2015;151(3):257–258. doi:10.1001/jamadermatol.2014.2034
Customize your JAMA Network experience by selecting one or more topics from the list below.